2025-12-30 - Analysis Report
Okay, here's a comprehensive report and analysis of Schrodinger Inc. (SDGR), based on the provided data.

**1) Return Rate Comparison**

*   **Company Overview:** Schrodinger Inc. is a company that develops software for drug discovery and materials science.
*   **SDGR Cumulative Return:** -54.34%
*   **VOO (S&P 500) Cumulative Return:** 71.37%
*   **Divergence:**
    *   Max: 42.2
    *   Min: -127.1
    *   Current: -125.0
    *   Relative Divergence: 1.2

**Analysis:**

SDGR has significantly underperformed the S&P 500 (VOO) over the analyzed period.  The current divergence is near the minimum observed historically, indicating substantial underperformance relative to the market.  A relative divergence of 1.2 suggests the underperformance is near its worst relative to the comparison.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
|------------|--------|-------|--------|-------|--------|
| 2020-2022  | -70.0% | 78.2% | -76.0% | 0.0   | 1.3    |
| 2021-2023  | -57.0% | 81.0% | -59.0% | -0.0  | 2.6    |
| 2022-2024  | 6.0%   | 81.0% | -14.0% | -0.0  | 1.4    |
| 2023-2025  | -3.0%  | 82.6% | -70.0% | -0.0  | 1.3    |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** The CAGR is negative for all periods except 2022-2024, indicating poor overall growth.
*   **MDD (Maximum Drawdown):** The high MDD figures (around 80%) signify substantial risk and volatility, meaning the stock has experienced significant declines from peak to trough.
*   **Alpha:** The negative Alpha values suggest that SDGR has consistently underperformed its expected return based on its risk (Beta).
*   **Beta:** A Beta near 0 suggests that SDGR's price is relatively uncorrelated to the market's (S&P 500) movements. This might indicate that company-specific factors are driving its performance more than broad market trends.
*   **Cap(B):** Market capitalization remains fairly steady between 1.3 and 2.6 billion dollars.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 18.31
*   **Last Market Data:** Price: 17.84, Previous Close: 18.31, Change: -2.57
*   **5-day SMA:** 18.51
*   **20-day SMA:** 17.90
*   **60-day SMA:** 18.95

**Analysis:**

*   The current price (17.84) is below the 5-day and 60-day SMAs, but slightly above the 20-day SMA. The fact that the price is below all the SMA's except the 20-day is a near-term bearish trend. The recent negative change (-2.57%) indicates downward price pressure.

**3) Technical Indicators and Signals**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommendation)
*   **RSI:** 56.69
*   **PPO:** 0.84
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (58 shares - Very Safe - MRI:0.90) Monthly invest 1.4% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -0.7 (Short-term Decline)
*   **Expected Return (%):** -5407.7%

**Analysis:**

*   **MRI:** The "Medium Investment" recommendation based on the MRI suggests moderate risk, implying it's not a high-conviction buy.
*   **RSI:** An RSI of 56.69 is neutral, not indicating overbought or oversold conditions.
*   **PPO:** A positive PPO (0.84) suggests the short-term moving average is above the long-term moving average, which can be a bullish signal, but must be considered with caution given the other indicators.
*   **Hybrid Signal:** The hybrid signal advocates for buying, which is inconsistent with the expected return data.
*   **Divergence Change:** The recent decline in relative divergence reinforces the short-term bearish trend.
*   **Expected Return:** The extremely negative expected return (-5407.7%) is concerning and warrants further investigation.  It could be a data error, an artifact of the model, or indicative of severe underlying problems.

**4) Recent News & Significant Events**

*   **Headlines:**
    *   "Unlocking Hidden Value in Schrodinger's Box" (Seeking Alpha)
    *   "Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now" (Yahoo Finance, Nasdaq)
    *   "$SDGR stock is up 14% today. Here's what we see in our data." (Quiver Quantitative)
    *   "Schr√∂dinger (NASDAQ: SDGR) and Copernic hit milestone; Neptune shows over 2x ammonia yield" (Stock Titan)
    *   "Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Rating of 'Hold' by Brokerages" (MarketBeat)

**Analysis:**

The news is mixed. While some articles suggest a potential "buy the bottom" opportunity, others highlight milestones and analyst ratings, but overall, there is not a strong consensus on the company's prospects. The "Hold" rating and the absence of overwhelmingly positive catalysts suggest a cautious approach.

**4-2) Analyst Opinions**

*   **Consensus:** Strong Buy (Mean: 1.44)
*   **Opinions:** 9
*   **Target Price:** Avg: $27.22, High: $33.00, Low: $18.00
*   **Recent Rating Changes:** Not provided

**Analysis:**

The analyst consensus is surprisingly optimistic, considering the underperformance. A "Strong Buy" rating with a mean of 1.44 suggests strong confidence from analysts. The average target price of $27.22 indicates substantial upside potential from the current price ($17.84). However, the wide range between the high and low target prices ($33 vs. $18) suggests uncertainty among analysts.

**5) Recent Earnings Analysis**

| Date       | EPS   | Revenue  |
|------------|-------|----------|
| 2025-11-05 | -0.45 | 0.05 B$  |
| 2025-08-06 | -0.59 | 0.05 B$  |
| 2025-05-07 | -0.82 | 0.06 B$  |
| 2024-11-12 | -0.52 | 0.04 B$  |
| 2025-11-05 | -0.52 | 0.04 B$  |

**Analysis:**

The company is consistently losing money, as evidenced by the negative EPS figures. Revenue is relatively stable but not sufficient to generate profits. The trend in EPS is concerning, with losses remaining consistent throughout the quarters.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.05B  | 51.61%        |
| 2025-06-30   | $0.05B  | 47.77%        |
| 2025-03-31   | $0.06B  | 52.26%        |
| 2024-12-31   | $0.09B  | 72.61%        |
| 2024-09-30   | $0.04B  | 50.24%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE       |
|--------------|---------|-----------|
| 2025-09-30   | $0.32B  | -10.21%   |
| 2025-06-30   | $0.34B  | -12.59%   |
| 2025-03-31   | $0.37B  | -16.01%   |
| 2024-12-31   | $0.42B  | -9.54%    |
| 2024-09-30   | $0.45B  | -8.49%    |

**Analysis:**

*   **Revenue:** Revenue fluctuates, with a peak in Q4 2024.
*   **Profit Margin:** Profit margins appear healthy, suggesting that when the company makes sales, it maintains a good profit margin.  The 72.61% in Q4 2024 is particularly high.  However, this doesn't translate to overall profitability due to other expenses.
*   **Equity:** Equity is decreasing over the analyzed periods, which is not a positive sign.
*   **ROE:** Negative ROE figures indicate that the company is not generating returns on its equity. The declining trend in ROE suggests worsening profitability.

**7) Comprehensive Analysis (Summary)**

Schrodinger Inc. (SDGR) is facing significant challenges. It has dramatically underperformed the S&P 500, exhibiting substantial volatility and negative Alpha.  While analyst consensus leans towards a "Strong Buy" with a considerable upside target price, the fundamental data paints a concerning picture. The company is consistently losing money (negative EPS and ROE), and its equity is declining.

The news is mixed, with some articles suggesting a potential "buy the bottom," but a recent "Hold" rating from brokerages indicates caution. The technical indicators are also mixed, with a neutral RSI and a Hybrid Signal suggesting a buy, but a negative divergence trend and extremely negative expected return raise red flags.

**Overall, the data suggests a high-risk investment. While analysts are optimistic and the stock may be oversold, the company's poor financial performance and negative trends cannot be ignored. A potential investment should be approached with extreme caution, and further due diligence is strongly recommended to understand the reasons behind the discrepancies between analyst opinions and fundamental data.**


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.